Logo image of LOOP

LOOP INDUSTRIES INC (LOOP) Stock Fundamental Analysis

NASDAQ:LOOP - Nasdaq - US5435181046 - Common Stock - Currency: USD

1.35  +0.09 (+7.14%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LOOP. LOOP was compared to 85 industry peers in the Chemicals industry. LOOP has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, LOOP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

LOOP had negative earnings in the past year.
In the past year LOOP has reported a negative cash flow from operations.
LOOP had negative earnings in each of the past 5 years.
LOOP had a negative operating cash flow in each of the past 5 years.
LOOP Yearly Net Income VS EBIT VS OCF VS FCFLOOP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of LOOP (-84.01%) is worse than 96.47% of its industry peers.
Industry RankSector Rank
ROA -84.01%
ROE N/A
ROIC N/A
ROA(3y)-78.72%
ROA(5y)-79.15%
ROE(3y)-1438.32%
ROE(5y)-904.67%
ROIC(3y)N/A
ROIC(5y)N/A
LOOP Yearly ROA, ROE, ROICLOOP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

1.3 Margins

LOOP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LOOP Yearly Profit, Operating, Gross MarginsLOOP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K -15K -20K

3

2. Health

2.1 Basic Checks

LOOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
LOOP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for LOOP has been increased compared to 5 years ago.
LOOP has a worse debt/assets ratio than last year.
LOOP Yearly Shares OutstandingLOOP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LOOP Yearly Total Debt VS Total AssetsLOOP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

LOOP has an Altman-Z score of -14.69. This is a bad value and indicates that LOOP is not financially healthy and even has some risk of bankruptcy.
LOOP has a Altman-Z score of -14.69. This is amonst the worse of the industry: LOOP underperforms 88.24% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.69
ROIC/WACCN/A
WACC7.8%
LOOP Yearly LT Debt VS Equity VS FCFLOOP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

2.3 Liquidity

LOOP has a Current Ratio of 2.81. This indicates that LOOP is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LOOP (2.81) is better than 81.18% of its industry peers.
LOOP has a Quick Ratio of 2.79. This indicates that LOOP is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LOOP (2.79) is better than 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 2.79
LOOP Yearly Current Assets VS Current LiabilitesLOOP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

LOOP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.00%, which is quite impressive.
LOOP shows a strong growth in Revenue. In the last year, the Revenue has grown by 8667.72%.
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)8667.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4100%

3.2 Future

LOOP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.47% yearly.
Based on estimates for the next years, LOOP will show a very strong growth in Revenue. The Revenue will grow by 169.01% on average per year.
EPS Next Y-55.43%
EPS Next 2Y30.71%
EPS Next 3Y51.21%
EPS Next 5Y72.47%
Revenue Next Year1107.86%
Revenue Next 2Y982.26%
Revenue Next 3Y439.34%
Revenue Next 5Y169.01%

3.3 Evolution

LOOP Yearly Revenue VS EstimatesLOOP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M
LOOP Yearly EPS VS EstimatesLOOP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LOOP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LOOP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LOOP Price Earnings VS Forward Price EarningsLOOP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LOOP Per share dataLOOP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

LOOP's earnings are expected to grow with 51.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y51.21%

0

5. Dividend

5.1 Amount

LOOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LOOP INDUSTRIES INC

NASDAQ:LOOP (7/25/2025, 3:10:45 PM)

1.35

+0.09 (+7.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-15 2025-07-15/amc
Earnings (Next)10-13 2025-10-13
Inst Owners14.85%
Inst Owner Change0%
Ins Owners1.87%
Ins Owner Change0.32%
Market Cap64.42M
Analysts84.44
Price Target4.01 (197.04%)
Short Float %2.51%
Short Ratio2.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)119.61%
Min EPS beat(2)1.96%
Max EPS beat(2)237.26%
EPS beat(4)4
Avg EPS beat(4)70.37%
Min EPS beat(4)1.96%
Max EPS beat(4)237.26%
EPS beat(8)6
Avg EPS beat(8)31.57%
EPS beat(12)9
Avg EPS beat(12)37.16%
EPS beat(16)10
Avg EPS beat(16)21.91%
Revenue beat(2)1
Avg Revenue beat(2)17872.8%
Min Revenue beat(2)-80.03%
Max Revenue beat(2)35825.6%
Revenue beat(4)2
Avg Revenue beat(4)8960.49%
Min Revenue beat(4)-80.03%
Max Revenue beat(4)35825.6%
Revenue beat(8)3
Avg Revenue beat(8)4487.42%
Revenue beat(12)4
Avg Revenue beat(12)2976.12%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.42%
PT rev (3m)-0.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)36.36%
EPS NY rev (1m)1.54%
EPS NY rev (3m)13.81%
Revenue NQ rev (1m)72.2%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-16.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.23
BVpS-0.06
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -84.01%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-78.72%
ROA(5y)-79.15%
ROE(3y)-1438.32%
ROE(5y)-904.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 79.88%
Cap/Sales 3.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.81
Quick Ratio 2.79
Altman-Z -14.69
F-Score5
WACC7.8%
ROIC/WACCN/A
Cap/Depr(3y)443.31%
Cap/Depr(5y)599.55%
Cap/Sales(3y)1434.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y-55.43%
EPS Next 2Y30.71%
EPS Next 3Y51.21%
EPS Next 5Y72.47%
Revenue 1Y (TTM)8667.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4100%
Revenue Next Year1107.86%
Revenue Next 2Y982.26%
Revenue Next 3Y439.34%
Revenue Next 5Y169.01%
EBIT growth 1Y83.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.1%
EBIT Next 3Y48.84%
EBIT Next 5Y89.44%
FCF growth 1Y94.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y95.53%
OCF growth 3YN/A
OCF growth 5YN/A